This company has been marked as potentially delisted and may not be actively trading. Vermillion (VRML) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock VRML vs. AWH, MYMD, NAVB, VNRX, EDAP, ANEB, MNOV, AKYA, MLSS, and IMMXShould you be buying Vermillion stock or one of its competitors? The main competitors of Vermillion include Aspira Women's Health (AWH), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), VolitionRx (VNRX), Edap Tms (EDAP), Anebulo Pharmaceuticals (ANEB), MediciNova (MNOV), Akoya Biosciences (AKYA), Milestone Scientific (MLSS), and Immix Biopharma (IMMX). These companies are all part of the "medical" sector. Vermillion vs. Its Competitors Aspira Women's Health MyMD Pharmaceuticals Navidea Biopharmaceuticals VolitionRx Edap Tms Anebulo Pharmaceuticals MediciNova Akoya Biosciences Milestone Scientific Immix Biopharma Vermillion (NASDAQ:VRML) and Aspira Women's Health (NASDAQ:AWH) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and community ranking. Does the MarketBeat Community prefer VRML or AWH? Vermillion received 190 more outperform votes than Aspira Women's Health when rated by MarketBeat users. Likewise, 66.67% of users gave Vermillion an outperform vote while only 16.87% of users gave Aspira Women's Health an outperform vote. CompanyUnderperformOutperformVermillionOutperform Votes20466.67% Underperform Votes10233.33% Aspira Women's HealthOutperform Votes1416.87%Underperform Votes6983.13% Which has more volatility and risk, VRML or AWH? Vermillion has a beta of 3.47, meaning that its stock price is 247% more volatile than the S&P 500. Comparatively, Aspira Women's Health has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500. Which has preferable valuation and earnings, VRML or AWH? Vermillion has higher earnings, but lower revenue than Aspira Women's Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVermillion$4.54M3.37-$15.24MN/AN/AAspira Women's Health$9.18M0.27-$16.69M-$0.98-0.08 Is VRML or AWH more profitable? Aspira Women's Health has a net margin of -165.07% compared to Vermillion's net margin of -307.31%. Aspira Women's Health's return on equity of 0.00% beat Vermillion's return on equity.Company Net Margins Return on Equity Return on Assets Vermillion-307.31% -155.25% -103.47% Aspira Women's Health -165.07%N/A -267.23% Do analysts prefer VRML or AWH? Aspira Women's Health has a consensus target price of $5.50, indicating a potential upside of 6,607.32%. Given Aspira Women's Health's stronger consensus rating and higher probable upside, analysts plainly believe Aspira Women's Health is more favorable than Vermillion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vermillion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aspira Women's Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor VRML or AWH? In the previous week, Vermillion's average media sentiment score of 0.00 equaled Aspira Women's Health'saverage media sentiment score. Company Overall Sentiment Vermillion Neutral Aspira Women's Health Neutral Do institutionals and insiders believe in VRML or AWH? 18.1% of Vermillion shares are owned by institutional investors. Comparatively, 12.2% of Aspira Women's Health shares are owned by institutional investors. 4.4% of Vermillion shares are owned by insiders. Comparatively, 4.3% of Aspira Women's Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryVermillion beats Aspira Women's Health on 8 of the 15 factors compared between the two stocks. Get Vermillion News Delivered to You Automatically Sign up to receive the latest news and ratings for VRML and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRML and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRML vs. The Competition Export to ExcelMetricVermillionDiagnostic Substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.31M$18.64M$5.19B$8.61BDividend YieldN/AN/A5.38%4.23%P/E Ratio-0.92N/A25.7419.50Price / Sales3.3715.98396.67119.91Price / CashN/AN/A35.5255.95Price / Book1.750.028.025.60Net Income-$15.24M-$15.61M$3.15B$248.44M Vermillion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRMLVermillionN/A$0.16-4.7%N/A-89.9%$15.31M$4.54M-0.9243Gap DownAWHAspira Women's Health1.004 of 5 stars$0.08-12.5%$5.50+6,607.3%-95.0%$2.44M$9.18M-0.07110High Trading VolumeMYMDMyMD PharmaceuticalsN/A$0.14-0.2%N/A-92.6%$331KN/A0.006Gap DownHigh Trading VolumeNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A+0.0%$20K$8.13K0.0010VNRXVolitionRx1.5982 of 5 stars$0.86-6.5%$3.50+306.9%+13.9%$88.61M$1.31M-2.3980Gap DownHigh Trading VolumeEDAPEdap Tms1.8888 of 5 stars$1.72+1.3%$8.50+394.2%-67.4%$63.49M$69.18M-2.77230ANEBAnebulo Pharmaceuticals2.7939 of 5 stars$1.52-1.3%$5.50+261.8%-43.2%$63.27MN/A-5.854News CoverageGap DownMNOVMediciNova2.4334 of 5 stars$1.31+1.6%$7.00+434.4%-2.2%$63.27M$1M-5.7010Positive NewsAKYAAkoya Biosciences1.3992 of 5 stars$1.29+2.4%$2.51+94.3%-48.1%$62.94M$81.67M-1.3390MLSSMilestone Scientific2.3691 of 5 stars$0.80-9.1%$1.25+56.4%+17.4%$62.70M$8.61M-11.4130IMMXImmix Biopharma3.2362 of 5 stars$2.23-0.4%$7.00+213.9%-1.8%$62.44MN/A-3.199 Related Companies and Tools Related Companies Aspira Women's Health Competitors MyMD Pharmaceuticals Competitors Navidea Biopharmaceuticals Competitors VolitionRx Competitors Edap Tms Competitors Anebulo Pharmaceuticals Competitors MediciNova Competitors Akoya Biosciences Competitors Milestone Scientific Competitors Immix Biopharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRML) was last updated on 6/25/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vermillion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vermillion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRML Stock Free VRML Stock Alerts